The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 02, 2021

Filed:

Jan. 06, 2020
Applicants:

Neon Therapeutics, Inc., Cambridge, MA (US);

Stichting Het Nederlands Kanker Instituut-antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, NL;

Inventors:

Marit M. Van Buuren, Belmont, MA (US);

Divya Reddy Lenkala, Watertown, MA (US);

Joost Huibert Van Den Berg, Amsterdam, NL;

Jessica Kohler, Boston, MA (US);

Matthew Goldstein, Jamaica Plain, MA (US);

Ed Fritsch, Concord, MA (US);

Renate De Boer, Diemen, NL;

Ton Schumacher, Aloemehomal, NL;

Noor Bakker, Stuyvesantstraat, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 5/07 (2010.01); C12N 5/0783 (2010.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); A61K 2039/5158 (2013.01); A61K 2039/572 (2013.01); C12N 2501/26 (2013.01); C12N 2501/998 (2013.01);
Abstract

The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.


Find Patent Forward Citations

Loading…